{
    "clinical_study": {
        "@rank": "75708", 
        "acronym": "BaChi-BloPro1", 
        "arm_group": [
            {
                "arm_group_label": "Moderate rocuronium neuromuscular blockade", 
                "arm_group_type": "Active Comparator", 
                "description": "rocuronium bolus is given if needed to maintain moderate neuromuscular blockade (TOF-count 2-4) during gastrojejunal anastomosis"
            }, 
            {
                "arm_group_label": "deep rocuronium neuromuscular blockade", 
                "arm_group_type": "Experimental", 
                "description": "rocuronium bolus is given if needed to maintain deep neuromuscular blockade (here defined as a Posttetanic Count 1 - 5) during gastrojejunal anastomosis"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether deep neuromuscular blockade  compared to\n      moderate neuromuscular blockade may improve the surgical conditions in patients undergoing\n      laparoscopic bariatric surgery."
        }, 
        "brief_title": "Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions", 
        "condition": [
            "Bariatric Surgery", 
            "Laparoscopic Bariatric Surgery", 
            "Robotic Bariatric Surgery", 
            "Gastric Bypass", 
            "Morbid Obesity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Obesity, Morbid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient between 18 and 64 years\n\n          -  indication for bariatric surgery accordingly to HAS\n\n          -  patient undergoing laparoscopic or robotic gastric bypass surgery\n\n          -  written informed consent\n\n          -  affiliation to social security\n\n        Non-inclusion Criteria:\n\n          -  known hypersensibility to any of the drugs used during this study\n\n          -  absence of written informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "64 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02118844", 
            "org_study_id": "2014-000289-23"
        }, 
        "intervention": {
            "arm_group_label": [
                "Moderate rocuronium neuromuscular blockade", 
                "deep rocuronium neuromuscular blockade"
            ], 
            "intervention_name": "rocuronium", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Rocuronium"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "bariatric surgery", 
            "surgical conditions", 
            "deep neuromuscular blockade"
        ], 
        "lastchanged_date": "April 23, 2014", 
        "location": {
            "contact": {
                "email": "t.fuchs-buder@chu-nancy.fr", 
                "last_name": "Thomas Fuchs-Buder, MD", 
                "phone": "#33.383.153942"
            }, 
            "facility": {
                "address": {
                    "city": "Vandoeuvre-Les-Nancy", 
                    "country": "France", 
                    "zip": "F-54511"
                }, 
                "name": "CHU Nancy/Brabois"
            }, 
            "investigator": [
                {
                    "last_name": "Thomas Fuchs-Buder, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Claude Meistelman, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Laurent Brunaud, MD, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Denis Schmartz, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Val\u00e9rie Jacques, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Thibaut Fouquet, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Thomas Serradoni, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Claire Nomin\u00e9, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Laparoscopic Bariatric Surgery: Impact of the Level of Neuromuscular Blockade on Surgical Conditions - Comparison Between Moderate and Deep Neuromuscular Blockade", 
        "other_outcome": [
            {
                "description": "The time from begin of the gastrojejunal anastomosis until the end will be measured in min. The surgeon indicate begin and end of the gastrojejunal anastomosis.", 
                "measure": "time needed to perform gastrojejunal anastomosis", 
                "safety_issue": "No", 
                "time_frame": "90 minutes"
            }, 
            {
                "description": "Concomitantly the the evaluation by the King score, the surgical conditions will be also evaluated by a 10 point VAS (visual-analog scale).This evaluation will also be realized by the surgeon, still blinded to the study arm.", 
                "measure": "10 point-VAS to evaluate surgical conditions", 
                "safety_issue": "No", 
                "time_frame": "2 x 15 minutes"
            }
        ], 
        "overall_contact": {
            "email": "t.fuchs-buder@chu-nancy.fr", 
            "last_name": "Thomas Fuchs-Buder, MD", 
            "phone": "#33.383.153942"
        }, 
        "overall_official": {
            "affiliation": "CHU Nancy, Department of Anaesthesia & Critical Care", 
            "last_name": "Thomas Fuchs-Buder, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The surgical conditions will be evaluated with the King Score (M. King et al Anesthesiology 2000; 93: 1392 - 97). This score is a 4-point score. The evaluation will be done by the surgeon who is blinded. An improvement of at least 1-point will be considered as clinical relevant.", 
            "measure": "Improvement of surgical conditions", 
            "safety_issue": "No", 
            "time_frame": "15 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02118844"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Concomitantly to the evaluation of the surgical conditions the pneumoperitoneal pressure (in mm Hg) generated by the Carbon dioxide insufflation will be registrated.", 
            "measure": "Pneumoperitoneum generated pressure", 
            "safety_issue": "No", 
            "time_frame": "15 minutes"
        }, 
        "source": "Central Hospital, Nancy, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Central Hospital, Nancy, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}